DK405576A - Fremgangsmade til fremstilling af vinyloge amidrazoner - Google Patents

Fremgangsmade til fremstilling af vinyloge amidrazoner

Info

Publication number
DK405576A
DK405576A DK405576A DK405576A DK405576A DK 405576 A DK405576 A DK 405576A DK 405576 A DK405576 A DK 405576A DK 405576 A DK405576 A DK 405576A DK 405576 A DK405576 A DK 405576A
Authority
DK
Denmark
Prior art keywords
vinyloge
amidra
zones
procedure
making
Prior art date
Application number
DK405576A
Other languages
English (en)
Inventor
H Amschler
W Schoetensack
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU73350A external-priority patent/LU73350A1/xx
Priority claimed from LU75301A external-priority patent/LU75301A1/xx
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of DK405576A publication Critical patent/DK405576A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK405576A 1975-09-09 1976-09-08 Fremgangsmade til fremstilling af vinyloge amidrazoner DK405576A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU73350A LU73350A1 (da) 1975-09-09 1975-09-09
LU75301A LU75301A1 (da) 1976-07-05 1976-07-05

Publications (1)

Publication Number Publication Date
DK405576A true DK405576A (da) 1977-03-10

Family

ID=26640189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK405576A DK405576A (da) 1975-09-09 1976-09-08 Fremgangsmade til fremstilling af vinyloge amidrazoner

Country Status (5)

Country Link
JP (1) JPS5262282A (da)
DE (1) DE2640186A1 (da)
DK (1) DK405576A (da)
FR (1) FR2323381A1 (da)
NL (1) NL7609941A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113788762B (zh) * 2021-08-13 2024-06-07 山东京博农化科技股份有限公司 一种采用固定床反应器制备3-二正丙胺基丙烯醛的方法

Also Published As

Publication number Publication date
FR2323381A1 (fr) 1977-04-08
JPS5262282A (en) 1977-05-23
NL7609941A (nl) 1977-03-11
DE2640186A1 (de) 1977-03-24

Similar Documents

Publication Publication Date Title
DK143706C (da) Fremgangsmaade til fremstilling af svovlholdige organosiliciumforbindelser
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK138900C (da) Fremgangsmaade til fremstilling af nucleosider
DK484576A (da) Fremgangsmade til fremstilling af 2-aroyl-3-phenyl-benzothiophenforbindelser
DK87876A (da) Fremgangsmade til fremstilling af n-acyl-l-metionin
DK243176A (da) Fremgangsmade til fremstilling af polycliske forbindelser
DK113476A (da) Fremgangsmade til fremstilling af amoxicillintrihydrat
DK353676A (da) Fremgangsmade til fremstilling af glasgenstande
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK93976A (da) Fremgangsmade til fremstilling af butyrophenonforbindelser
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK357576A (da) Fremgangsmade til fremstilling af indoler
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK283476A (da) Fremgangsmade til fremstilling af beta-acylpyrroler
DK575576A (da) Fremgangsmade til fremstilling af krystallinske former af natrium-cefamandol
DK435776A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK435876A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK397076A (da) Fremgangsmade til fremstilling af nikotinamid
DK484776A (da) Fremgangsmade til fremstilling af aroylphenylnaphthalen-forbindelser
DK351876A (da) Fremgangsmade til fremstilling af echinenon
DK246976A (da) Fremgangsmade til fremstilling af isoquinoliner
DK366676A (da) Fremgangsmade til fremstilling af slagseje polyvinylaromater
DK146593C (da) Analogifremgangsmaade til fremstilling af fluorprostaglandiner
DK174676A (da) Fremgangsmade til fremstilling af phosphornitrider
DK343576A (da) Fremgangsmade til fremstilling af styrylamidiner